Rowland Thomas Andrew sold ANIP
March 11, 2026 · Form 4 insider transaction
Rowland Thomas Andrew sold 4,772 shares of ANI Pharmaceuticals, Inc. at $74.91 per share, a transaction worth $357.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,772
Price
$74.91
Total value
$357.5K
InsiderRowland Thomas Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 11, 2026
Filing dateMarch 13, 2026
Shares owned after38,730
OwnershipDirect
10b5-1 planNo
AmendedNo